Dr. Kaat Guldolf - Neurologie SRL
Dr. Kaat Guldolf - Neurologie reported total assets of 186,087 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jan 2026).
The score of Dr. Kaat Guldolf - Neurologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Kaat Guldolf - Neurologie's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 05 Jan 2026
- Year ended 30 Jun 2024filed on 03 Jan 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 22 Dec 2022
Dr. Kaat Guldolf - Neurologie's financial analysis
- Solvency88.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Kaat Guldolf - Neurologie
Dr. Kaat Guldolf - Neurologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.535.077
- VAT number
- BE0755535077
- Peppol
- Registered · 0208:0755535077 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2020
- Registered office
- 9190 Stekene
- Latest accounts
- 2025 · filed on 05 Jan 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Kaat Guldolf - Neurologie (SRL) has been based in Stekene since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 81,951 € and equity of 165,075 €; its revenue is not published. Its solvency stands at 88.7%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Kaat Guldolf - Neurologie
Companies in the same business, of comparable size and area, outside its group.
- Dokter Pepijn Mooren Medical specialists activities Antwerp · balance sheet 187,314 €
- Dr. Tim Kelderman, neurologie Medical specialists activities Antwerp · balance sheet 187,882 €
- Kalonji M.K. Medical specialists activities Charleroi · balance sheet 188,033 €
- Dr Morello Caroline Ophtalmologie Medical specialists activities Uccle · balance sheet 184,074 €
- Dr. Jan F. J. Hendrickx Medical specialists activities Brecht · balance sheet 183,919 €
- Dr. Sophie Samyn Medical specialists activities Vilvoorde · balance sheet 186,064 €
- Bold Ionela Medical specialists activities Brussels · balance sheet 483,457 €
- DocRoyezPsy Medical specialists activities Gembloux · balance sheet 186,243 €
Frequently asked questions about Dr. Kaat Guldolf - Neurologie
What is the revenue of Dr. Kaat Guldolf - Neurologie?
Dr. Kaat Guldolf - Neurologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Kaat Guldolf - Neurologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0755535077 for Dr. Kaat Guldolf - Neurologie, if the company is VAT-registered. Its company number (CBE) is 0755.535.077.
Where is the registered office of Dr. Kaat Guldolf - Neurologie?
According to the CBE register, the registered office of Dr. Kaat Guldolf - Neurologie is in 9190 Stekene.
What is the equity of Dr. Kaat Guldolf - Neurologie?
At the close of the 2025 financial year, the equity of Dr. Kaat Guldolf - Neurologie amounts to 165,075 €, a solvency of 88.7% of total assets.
Who manages Dr. Kaat Guldolf - Neurologie?
The register lists 1 active mandates at Dr. Kaat Guldolf - Neurologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Kaat Guldolf - Neurologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →